1. Adamczyk-Grochala, Jagoda, Bloniarz, Dominika, Zielinska, Klaudia, Lewinska, Anna, Wnuk, Maciej. 2022. DNMT2/TRDMT1 gene knockout compromises doxorubicin-induced unfolded protein response and sensitizes cancer cells to ER stress-induced apoptosis. In Apoptosis : an international journal on programmed cell death, 28, 166-185. doi:10.1007/s10495-022-01779-0. https://pubmed.ncbi.nlm.nih.gov/36273376/
2. Lewinska, Anna, Adamczyk-Grochala, Jagoda, Wnuk, Maciej. 2023. TRDMT1-mediated RNA C-5 methylation as a novel target in anticancer therapy. In Biochimica et biophysica acta. Reviews on cancer, 1878, 188964. doi:10.1016/j.bbcan.2023.188964. https://pubmed.ncbi.nlm.nih.gov/37625528/
3. Bloniarz, Dominika, Adamczyk-Grochala, Jagoda, Lewinska, Anna, Wnuk, Maciej. 2021. The lack of functional DNMT2/TRDMT1 gene modulates cancer cell responses during drug-induced senescence. In Aging, 13, 15833-15874. doi:10.18632/aging.203203. https://pubmed.ncbi.nlm.nih.gov/34139673/
4. Zabek, Tomasz, Szmatola, Tomasz, Adamczyk-Grochala, Jagoda, Lewinska, Anna, Wnuk, Maciej. 2023. Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells. In Journal of neuro-oncology, 163, 61-69. doi:10.1007/s11060-023-04304-8. https://pubmed.ncbi.nlm.nih.gov/37169948/
5. Xue, Songlei, Xu, Hui, Sun, Zhen, Hu, Xuming, Cui, Hengmi. 2019. Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration. In Biochemical and biophysical research communications, 520, 60-66. doi:10.1016/j.bbrc.2019.09.098. https://pubmed.ncbi.nlm.nih.gov/31570165/